The company said in a statement on Monday that the losses were due to the fact that it has failed to collect debts from the Government of Zambia, increased competition from other companies that produce similar products and reduction in drug prices.
Cipla is struggling to make money from drug sales. Photo by UIA
You need to Log in
and be a client to read this story in full and get access to audio and images.